Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
LCAR-B38M治疗复发或难治性多发性骨髓瘤的四年随访:一项在中国开展的1期、单臂、开放标签、多中心研究(LEGEND-2)
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-022-01301-8
Zhao, Wan-Hong; Wang, Bai-Yan; Chen, Li-Juan; Fu, Wei-Jun; Xu, Jie; Liu, Jie; Jin, Shi-Wei; Chen, Yin-Xia; Cao, Xing-Mei; Yang, Yun; Zhang, Yi-Lin; Wang, Fang-Xia; Zhang, Peng-Yu; Lei, Bo; Gu, Liu-Fang; Wang, Jian-Li; Zhang, Hui; Bai, Ju; Xu, Yan; Zhu, Han; Du, Juan; Jiang, Hua; Fan, Xiao-Hu; Li, Jian-Yong; Hou, Jian; Chen, Zhu; Zhang, Wang-Gang; Mi, Jian-Qing; Chen, Sai-Juan; He, Ai-Li